NEW YORK (CBS.MW) -- SuperGen Inc. said it has received approval of its abbreviated new drug application for its Paclitaxel injection in a number of dosages from the Food and Drug Administration.

The certification is a milestone for Kexing Biopharm, whose first drug for cancer therapy, Paclitaxel for Injection (Albumin Bound) , can now be registered in the EU as the company overcomes the ...

Some people stop nab-paclitaxel due to side effects so they may continue atezolizumab on its own. If this happens you may have it as an injection under your skin. When you are having this treatment ...

Alembic Pharmaceuticals Limited announced that the US Food and Drug Administration (USFDA) has granted final approval for its Abbreviated New Drug Application (ANDA) for Paclitaxel Injection USP ...

Researchers compare relacorilant plus nab-paclitaxel with nab-paclitaxel monotherapy in patients with platinum-resistant ...

Dublin, March 27, 2025 (GLOBE NEWSWIRE) -- The "Paclitaxel Injection Market Report 2025"has been added to ResearchAndMarkets.com's offering. This report covers market characteristics, size and growth, ...

The certification is a milestone for Kexing Biopharm, whose first drug for cancer therapy, Paclitaxel for Injection (Albumin Bound) , can now be registered in the EU as the company overcomes the ...